Susan Graf

Président chez FINCH THERAPEUTICS GROUP, INC.

Fortune : 374 $ au 30/04/2024

52 ans

84 relations

Health Technology

Consumer Services

Health Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Ronald D. Gunn	M	63	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Arthur Kuan	M	34	CG ONCOLOGY, INC.	7 ans
Chris Shumway	M	58	FINCH THERAPEUTICS GROUP, INC.	4 ans
Elder Granger	M	70	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	2 ans
Victor Tong	M	41	CG ONCOLOGY, INC.	1 ans
Hong Fang Song	F	59	CG ONCOLOGY, INC.	9 ans
Ned Ruffin	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jeffery Smisek	M	69	FINCH THERAPEUTICS GROUP, INC.	7 ans
James Mulé	M	72	CG ONCOLOGY, INC.	6 ans
Ambaw Bellete	M	54	CG ONCOLOGY, INC.	1 ans
Christian Lange	M	44	FINCH THERAPEUTICS GROUP, INC.	7 ans
Michael Wells	M	55	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Domenic Ferrante	M	58	FINCH THERAPEUTICS GROUP, INC.	5 ans
Leonard Post	M	72	CG ONCOLOGY, INC.	6 ans
Brian Liu	M	36	CG ONCOLOGY, INC.	2 ans
Matthew Nelson	M	-	FINCH THERAPEUTICS GROUP, INC.	3 ans
Randy Raisman	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jim Lenehan	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Matthew Blischak	M	-	FINCH THERAPEUTICS GROUP, INC.	1 ans
Vijay Kasturi	M	57	CG ONCOLOGY, INC.	1 ans
Lance Thibault	M	58	FINCH THERAPEUTICS GROUP, INC.	1 ans
Sonia Timberlake	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Erin Graves	M	-	EPIZYME, INC.	7 ans
Michelle L. Rose	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Bing Kung	M	-	CG ONCOLOGY, INC.	-
Evan Bedil	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	3 ans
Swapnil Bhargava	M	-	CG ONCOLOGY, INC.	1 ans

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Andrew Singer	M	53	EPIZYME, INC.	2 ans
Suzanne Fleming	F	63	EPIZYME, INC.	2 ans
Matthew Ros	M	57	EPIZYME, INC.	5 ans
Andrew Noh	M	-	FINCH THERAPEUTICS GROUP, INC.	4 ans
Mark Smith	M	37	FINCH THERAPEUTICS GROUP, INC.	6 ans
Marc Blaustein	M	61	FINCH THERAPEUTICS GROUP, INC.	2 ans
Francois Nader	M	67	NPS PHARMACEUTICALS, INC.	7 ans
Joseph Vittiglio	M	52	FINCH THERAPEUTICS GROUP, INC.	2 ans
Edward H. Stratemeier	M	75	NPS PHARMACEUTICALS, INC.	5 ans
Joseph Beaulieu	M	43	EPIZYME, INC.	5 ans
Christine Cvijic	F	46	NPS PHARMACEUTICALS, INC.	1 ans
Pedro Granadillo	M	77	NPS PHARMACEUTICALS, INC.	5 ans
Julie DiCarlo	F	-	EPIZYME, INC.	-
Brendan P. Rae	M	-	NPS PHARMACEUTICALS, INC.	1 ans
Zain Kassam	M	42	FINCH THERAPEUTICS GROUP, INC.	4 ans
Nicholas Haft	M	35	FINCH THERAPEUTICS GROUP, INC.	3 ans
Anne Marie Conway	F	-	FINCH THERAPEUTICS GROUP, INC.	-
Christine Mikail,	-	-	NPS PHARMACEUTICALS, INC.	1 ans
Samuel Hamood	M	56	FINCH THERAPEUTICS GROUP, INC.	-
Colin Broom	M	68	NPS PHARMACEUTICALS, INC.	6 ans
Roger Garceau	M	70	NPS PHARMACEUTICALS, INC.	7 ans
Michael Bonney	M	65	NPS PHARMACEUTICALS, INC.	10 ans
Tai Ching Ho	M	62	EPIZYME, INC.	3 ans
Kevin Conroy	M	58	EPIZYME, INC.	5 ans
Gregory Perry	M	63	FINCH THERAPEUTICS GROUP, INC.	4 ans
John F. Weidenbruch	M	63	EPIZYME, INC.	5 ans
Shefali Agarwal	M	50	EPIZYME, INC.	4 ans
Debra Silberg	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Vishal Kapoor	M	48	NPS PHARMACEUTICALS, INC.	1 ans
Andrea Edwards	F	-	EPIZYME, INC.	3 ans
Jason Fredette	M	-	EPIZYME, INC.	-
Chris Weidenmaier	M	-	FINCH THERAPEUTICS GROUP, INC.	-
John Bishop	M	62	EPIZYME, INC.	4 ans
David Rhodes	M	-	FINCH THERAPEUTICS GROUP, INC.	3 ans
Ralf H. Rosskamp	M	71	NPS PHARMACEUTICALS, INC.	2 ans
David Pugatch	M	-	FINCH THERAPEUTICS GROUP, INC.	2 ans
Robert Copeland	M	-	EPIZYME, INC.	9 ans
Bryan Gillis	M	-	FINCH THERAPEUTICS GROUP, INC.	1 ans
Zoran Zdraveski	M	54	EPIZYME, INC.	5 ans
Eric Pauwels	M	63	NPS PHARMACEUTICALS, INC.	4 ans
Marcio Souza	M	45	NPS PHARMACEUTICALS, INC.	2 ans
Alka Batycky	M	54	FINCH THERAPEUTICS GROUP, INC.	1 ans
Scott Wilhoit	M	61	NPS PHARMACEUTICALS, INC.	2 ans
Susan M. Mesco	F	-	NPS PHARMACEUTICALS, INC.	7 ans
Pierre Legault	M	63	NPS PHARMACEUTICALS, INC.	1 ans
Robin D. Friedman	F	-	NPS PHARMACEUTICALS, INC.	1 ans
Kenneth Bahrt	M	71	NPS PHARMACEUTICALS, INC.	1 ans
Luke Beshar	M	65	NPS PHARMACEUTICALS, INC.	8 ans
Ellen Rosenberg	F	61	NPS PHARMACEUTICALS, INC.	-
Alyssa Wyant	F	49	NPS PHARMACEUTICALS, INC.	3 ans
Pamela Strode	F	-	EPIZYME, INC.	3 ans
Glenn R. Melrose	M	68	NPS PHARMACEUTICALS, INC.	2 ans
Dhiren D'silva	M	-	NPS PHARMACEUTICALS, INC.	2 ans
Rebecca Cohen	F	-	EPIZYME, INC.	-
Patrik Florencio	M	-	NPS PHARMACEUTICALS, INC.	1 ans
Paul Firuta	M	58	NPS PHARMACEUTICALS, INC.	1 ans
Leah Neufeld	F	51	NPS PHARMACEUTICALS, INC.	1 ans

Statistiques

Pays	Relations	% du total
Etats-Unis	84	100,00%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations

Bourse
Insiders
Susan Graf
Réseau Personnel